Improving Clinical Outcomes Starts with Better Technology

Posted by Kevin Harris, President at CureMetrix on Jul 8, 2021 3:25:34 PM

Women have far better chances of survival if their breast cancer is diagnosed and treated early. Unfortunately, despite the best efforts of radiologists, nearly one third of breast cancer cases are missed in early mammogram screenings.

Read More

Topics: radiology, AI, breast cancer, mammogram, cmTriage, cmAssist, artificial intelligence, mammography, screening, CAD, AI-CAD, Machine Learning, breast cancer awareness, AI Mammogram, Breast imaging, BI-RADS Atlas 5th Edition, FFPI, Dense Breast, BRCA, breast density, CHD, heart disease, cmdensity, SBI, NCBC, ECR

Breast Cancer Screening Gets Personal | DOTmed

Posted by Navid Alipour, Chief Executive Officer on Jul 7, 2021 10:33:35 AM

Focused on Women’s Health, CureMetrix AI-based cmAngio™ was highlighted in the July 2021 edition of DOTmed HealthCareBusiness News.  cmAngio “represents the potential to screen 40 million women a year for heart disease in the U.S. alone,” with AI that maximizes the mammogram for both breast cancer and heart disease detection.

Read More

Topics: News, AI, mammogram, cmTriage, cmAssist, AI Mammogram, CHD, heart disease, cmangio

New Research Confirms Impact of CureMetrix AI on Improving Breast Cancer and Heart Disease Detection

Posted by Kevin Harris, President at CureMetrix on May 17, 2021 9:00:00 AM

 

Studies presented at major radiology conferences demonstrate the efficacy
of artificial intelligence solutions across key value points for radiology

Read More

Topics: radiology, AI, breast cancer, mammogram, cmTriage, cmAssist, artificial intelligence, mammography, screening, CAD, AI-CAD, Machine Learning, breast cancer awareness, AI Mammogram, Breast imaging, BI-RADS Atlas 5th Edition, FFPI, Dense Breast, BRCA, breast density, CHD, heart disease, cmdensity, SBI, NCBC, ECR

AI Test Drive - CureMetrix Highlights Mammo AI Study Results

Posted by Dawn Anderson on Dec 7, 2020 12:53:27 PM

As published by AuntMinnie.com - Dec 1, 2020:

Computer-aided detection (CAD) software developer CureMetrix reported in a Tuesday morning presentation at the virtual RSNA 2020 meeting that radiologists who used its mammography artificial intelligence (AI) software in a recent challenge were more accurate than those who didn't utilize the technology.

In a "Test Drive Challenge" study performed by the company in collaboration with Ambra Health, CureMetrix found that radiologists who used its AI software had improved sensitivity and specificity for detecting breast cancer compared with those who didn't. They also read normal cases much faster than those who interpreted the exams without the aid of AI software, said Kevin Harris, president of CureMetrix.

In the study, CureMetrix first invited seven experienced radiologists to read an enriched test of 25 mammograms, which included 19 normal and six biopsy-confirmed cancer cases, according to the vendor. These exams were interpreted without the use of AI on a research platform created by Ambra, according to the vendor.

Next, 30 other radiologists who volunteered to participate in the challenge read the same cases on the same platform, but with help from AI. In this part of the study, the radiologists were given a worklist of the 25 mammograms that had been prioritized by the firm's cmTriage mammography triage software by level of cancer suspicion. They then interpreted the exams with help from the vendor's cmAssist algorithm, which identifies, marks, and scores suspicious lesions for review by the radiologist, according to CureMetrix.

Radiologist performance on test set of 25 screening mammograms
  Radiologists without AI Radiologists with AI Percentage improvement
Sensitivity 71% 75% 5%
Specificity 56% 75% 34%
Accuracy 60% 75% 25%

The improvements were seen across all levels of reader experience, according to the company.

In addition, the radiologists were able to read normal exams 40% faster with use of AI, CureMetrix said.

Read More

Topics: News, AI, mammogram, cmTriage, cmAssist

What's New | DOTmed

Posted by Brock Anderson on Jul 13, 2020 2:07:40 PM

As mentioned in the July 2020 edition of DOTmed HealthCareBusiness News, CureMetrix was highlighted as a healthcare innovator for women's health and as a breast imaging product that helps with coronavirus backlog. With the COVID-19 pandemic pushing back breast cancer screenings for many patients, there is more reason than ever to bring products to the market that help radiologists manage their growing worklists.

Read More

Topics: News, AI, mammogram, cmTriage, cmAssist

COVID 19 and Radiology

Posted by Kevin Harris, President at CureMetrix on Mar 31, 2020 11:06:28 AM

COVID 19 and Radiology: There's Never Been a Better Time for AI

The COVID 19 pandemic has already overwhelmed our healthcare system, creating a ripple effect that puts additional strain on radiologists—and this will have serious impacts on breast cancer patient outcomes. In order to enforce social distancing and preserve resources for critically ill coronavirus patients, many imaging centers have put routine scheduled screening mammograms on hold for now. However, this means that those imaging centers will soon have to deal with the challenge of managing backlogs, keeping up with patient demand and ensuring accuracy in diagnosis at the same time.

Read More

Topics: radiology, mammogram, cmTriage, covid19, cmAssist, artificial intelligence, mammography